Create Medic Lifts Dividend as Profits Rebound on Higher Sales

Create Medic Co., Ltd. ( (JP:5187) ) has shared an update.

Create Medic reported a 4.5% rise in net sales to ¥13.62 billion for the year ended December 31, 2025, with operating profit surging 45.1% and ordinary profit up 31.7%, although profit attributable to owners fell 15.1% due partly to a lower share count impact. The company strengthened its financial base with an equity ratio above 80%, increased its annual dividend from ¥39 to ¥45 per share, and issued guidance for modest sales and profit growth in 2026, signaling a continued focus on stable earnings and shareholder returns.

The balance sheet remained solid, with total assets roughly flat at about ¥20.1 billion and net assets rising to ¥16.33 billion, while cash and equivalents declined on higher dividend payments and treasury stock purchases. For fiscal 2026, Create Medic forecasts net sales of ¥13.96 billion and profit attributable to owners of ¥750 million, implying mid-single-digit earnings growth and an expected further dividend increase, underscoring management’s confidence in steady demand and disciplined capital allocation in the medical device sector.

The most recent analyst rating on (JP:5187) stock is a Buy with a Yen1306.00 price target. To see the full list of analyst forecasts on Create Medic Co., Ltd. stock, see the JP:5187 Stock Forecast page.

More about Create Medic Co., Ltd.

Create Medic Co., Ltd. is a Tokyo Standard-listed Japanese medical device manufacturer specializing in products for hospital and clinical use. The company focuses on stable, profitability-oriented operations, maintaining a high equity ratio and consistent shareholder returns in the healthcare equipment market.

Average Trading Volume: 9,264

Technical Sentiment Signal: Buy

Current Market Cap: Yen10.46B

For detailed information about 5187 stock, go to TipRanks’ Stock Analysis page.